Boston continues its development because the nation’s high biopharma cluster with the announcement by GenesisM that it had damaged floor on its 154,000-sq-ft Class A biomanufacturing facility in close by Bedford, MA. GenesisM is a three way partnership between Bain Capital Actual Property and Botanic Properties.
The mission marks a major step ahead in addressing the vital want for purpose-built life sciences manufacturing infrastructure within the Higher Boston area, in accordance with Joshua Zinns, managing principal of Botanic Properties, including that GenesisM’s proprietary enhanced core design offers a robust preliminary build-out that reduces tenant fit-out time and capital prices.
The power, which is designed to help a number of tenants working independently inside regulated manufacturing suites, will characteristic 27-foot ceiling heights, as much as 18 loading berths, 12,000 amps of energy, and 40′ x 40′ column spacing. GenesisM’s enhanced core platform is designed to offer long-term operational flexibility, speed up buildout timelines, and scale back upfront capital necessities for tenants, continued Zinns.
Building is at present underway, with tenant fit-out commencing as early as Q2 2026 and closing core and shell supply anticipated in Q3 2026.
